Inauguration of Biogaran's activities in Guinea!
Biogaran officially inaugurates its activities in Guinea after nearly 2 years of presence in the country.
The year 2022 has begun in the best possible way for Biogaran, which has officially inaugurated its activities in Guinea after nearly two years of presence in the country. Biogaran marks a new strong act in favor of access to healthcare for all in West and Central Africa.
From left to right: Dr. N’faly Condé, representative of the DNPM, Pr. Hassane Bah, President of the Order of Physicians, Pr. Amara Cissé, former Minister of Health and President of the Society of Neurology, Rana Mourra, Head of Biogaran Operations in West and Central Africa
The pharmaceutical laboratory Biogaran officially inaugurated its activities in Guinea on January 28, 2022. The inauguration ceremony took place at the Hotel Noom in Conakry in the presence of several officials and professionals from the health sector as well as distinguished personalities such as Dr. N’faly Condé, representative of the DNPM, Pr. Hassane Bah, President of the Order of Physicians and Pr. Amara Cissé, former Minister of Health and President of the Society of Neurology.
This inauguration ceremony in Guinea allows Biogaran to pursue its ambition to make quality medicines accessible to all, after having deployed its operations in nearly 10 sub-Saharan African countries since 2019, including Senegal, Côte d’Ivoire or Mali.
Addressing public health issues
The availability of quality generic medicines, distributed in state-approved pharmacies, is of particular importance to Biogaran in Guinea and more generally in sub-Saharan Africa where the WHO estimates that 42% of medicines in circulation are counterfeit1. According to the World Health Organization, counterfeit medicines are responsible for at least 100,000 deaths in Africa each year².
In this context, Biogaran’s objective is to offer patients safe, effective medicines imported directly from France, where they treat millions of patients every year. Biogaran medicines are bioequivalent to their original drug, are 89% manufactured in Europe and 50% in France and comply with the strictest European manufacturing standards. In addition, the tamper-proof packaging of Biogaran medicines guarantees the authenticity and safety of the treatment to patients and health professionals.
Biogaran medicines marketed in the country are aimed at treating some of the most common pathologies on the African continent such as hypertension and diabetes. According to the WHO, 46% of African adults over the age of 25 suffer from high blood pressure3 and diabetes is responsible for nearly 9% of deaths in sub-Saharan Africa according to the International Diabetes Federation4.
Biogaran’s generic medicines available to patients in Guinea cover 9 therapeutic areas and allow for the treatment of these pathologies as well as other serious conditions such as cancer, infections and inflammation.
Commitment to healthcare professionals and patients
In 2020, Biogaran created the Académie Biogaran, a free continuing education program for African healthcare professionals. Taking the form of webinars, organized every two months, they allow health professionals to exchange and learn about various health topics. Through this training program, Biogaran is committed to providing healthcare professionals with quality medical information.
Supporting patients is also essential for Biogaran, which provides them with therapeutic education tools to help them better understand and cope with their disease. In addition, the tamper-proof packaging of Biogaran medicines guarantees that they are taking safe and effective medication.
Biogaran will also participate in solidarity actions in Guinea to facilitate the screening and diagnosis of patients with very common diseases in the country, such as diabetes and high blood pressure.
Biogaran in Guinea
Present in Guinea since March 2020, Biogaran aims to provide access to quality care for patients in Guinea. The inauguration of Biogaran’s activities in Guinea will help meet the demand for quality pharmaceutical products at a fair price that can be used safely.
You can consult the list of medicines available in Guinea by clicking here.
1 in 10 medicines in developing countries are substandard or falsified – WHO – November 28, 2017
2. United Nations – Africa Renewal – Counterfeit drugs raise Africa’s temperature – 2013
3. World Hypertension Panorama – World Health Organization – 2013
4. The ravages of diabetes in Africa – French Federation of Diabetics